Do analysts rate NVNO or AEMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33 Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has better valuation and earnings, NVNO or AEMD?

enVVeno Medical is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio enVVeno Medical N/A N/A -$19.47M -$25.54 N/A Aethlon Medical N/A N/A -$7.15M -$14.69 N/A

Is NVNO or AEMD more profitable?

enVVeno Medical's return on equity of -66.39% beat Aethlon Medical's return on equity. Company Net Margins Return on Equity Return on Assets enVVeno Medical N/A -66.39% -60.42% Aethlon Medical N/A -137.73% -105.87%

Does the media prefer NVNO or AEMD?

In the previous week, Aethlon Medical had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 3 mentions for Aethlon Medical and 2 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.02 beat Aethlon Medical's score of 0.53 indicating that enVVeno Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment enVVeno Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aethlon Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate AEMD or NXL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Nexalin Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer AEMD or NXL?

In the previous week, Aethlon Medical had 1 more articles in the media than Nexalin Technology. MarketBeat recorded 3 mentions for Aethlon Medical and 2 mentions for Nexalin Technology. Nexalin Technology's average media sentiment score of 1.89 beat Aethlon Medical's score of 0.53 indicating that Nexalin Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nexalin Technology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts recommend VVOS or AEMD?

Vivos Therapeutics currently has a consensus target price of $2.80, indicating a potential upside of 587.96%. Given Vivos Therapeutics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Vivos Therapeutics is more favorable than Aethlon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vivos Therapeutics 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to VVOS or AEMD?

In the previous week, Aethlon Medical had 1 more articles in the media than Vivos Therapeutics. MarketBeat recorded 3 mentions for Aethlon Medical and 2 mentions for Vivos Therapeutics. Vivos Therapeutics' average media sentiment score of 0.94 beat Aethlon Medical's score of 0.53 indicating that Vivos Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vivos Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aethlon Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend XAIR or AEMD?

Beyond Air presently has a consensus price target of $200.00, indicating a potential upside of 3,510.11%. Given Beyond Air's stronger consensus rating and higher possible upside, research analysts plainly believe Beyond Air is more favorable than Aethlon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beyond Air 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is XAIR or AEMD more profitable?

Aethlon Medical has a net margin of 0.00% compared to Beyond Air's net margin of -432.99%. Aethlon Medical's return on equity of -137.73% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Beyond Air -432.99% -350.00% -101.34% Aethlon Medical N/A -137.73% -105.87%

Does the media refer more to XAIR or AEMD?

In the previous week, Beyond Air had 1 more articles in the media than Aethlon Medical. MarketBeat recorded 4 mentions for Beyond Air and 3 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 0.53 beat Beyond Air's score of -0.05 indicating that Aethlon Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beyond Air 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aethlon Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer AEMD or CLGN?

CollPlant Biotechnologies has a consensus price target of $11.50, indicating a potential upside of 3,312.46%. Given CollPlant Biotechnologies' stronger consensus rating and higher possible upside, analysts plainly believe CollPlant Biotechnologies is more favorable than Aethlon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 CollPlant Biotechnologies 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Aethlon Medical (AEMD) Competitors

$0.72 +0.03 (+4.15%)

As of 02:45 PM Eastern

Compare

AEMD vs. NVNO, NXL, VVOS, XAIR, and CLGN

Should you buy Aethlon Medical stock or one of its competitors? MarketBeat compares Aethlon Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aethlon Medical include enVVeno Medical (NVNO), Nexalin Technology (NXL), Vivos Therapeutics (VVOS), Beyond Air (XAIR), and CollPlant Biotechnologies (CLGN). These companies are all part of the "medical equipment" industry.

How does Aethlon Medical compare to enVVeno Medical?

enVVeno Medical (NASDAQ:NVNO) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability.

enVVeno Medical's return on equity of -66.39% beat Aethlon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
enVVeno Medical	N/A	-66.39%	-60.42%
Aethlon Medical	N/A	-137.73%	-105.87%

In the previous week, Aethlon Medical had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 3 mentions for Aethlon Medical and 2 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.02 beat Aethlon Medical's score of 0.53 indicating that enVVeno Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
enVVeno Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aethlon Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

enVVeno Medical is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enVVeno Medical	N/A	N/A	-$19.47M	-$25.54	N/A
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A

34.7% of enVVeno Medical shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 15.0% of enVVeno Medical shares are held by company insiders. Comparatively, 0.7% of Aethlon Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

enVVeno Medical has a beta of 1.09, indicating that its stock price is 9% more volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market.

Summary

enVVeno Medical beats Aethlon Medical on 7 of the 12 factors compared between the two stocks.

How does Aethlon Medical compare to Nexalin Technology?

Aethlon Medical (NASDAQ:AEMD) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Nexalin Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 0.6% of Nexalin Technology shares are held by institutional investors. 0.7% of Aethlon Medical shares are held by company insiders. Comparatively, 25.3% of Nexalin Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Aethlon Medical has a net margin of 0.00% compared to Nexalin Technology's net margin of -3,018.12%. Aethlon Medical's return on equity of -137.73% beat Nexalin Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-137.73%	-105.87%
Nexalin Technology	-3,018.12%	-191.88%	-166.43%

Aethlon Medical has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market. Comparatively, Nexalin Technology has a beta of 4, indicating that its share price is 300% more volatile than the broader market.

In the previous week, Aethlon Medical had 1 more articles in the media than Nexalin Technology. MarketBeat recorded 3 mentions for Aethlon Medical and 2 mentions for Nexalin Technology. Nexalin Technology's average media sentiment score of 1.89 beat Aethlon Medical's score of 0.53 indicating that Nexalin Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aethlon Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nexalin Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Aethlon Medical has higher earnings, but lower revenue than Nexalin Technology. Nexalin Technology is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A
Nexalin Technology	$275.58K	36.26	-$8.22M	-$0.47	N/A

Summary

Aethlon Medical beats Nexalin Technology on 8 of the 13 factors compared between the two stocks.

How does Aethlon Medical compare to Vivos Therapeutics?

Vivos Therapeutics (NASDAQ:VVOS) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Vivos Therapeutics currently has a consensus target price of $2.80, indicating a potential upside of 587.96%. Given Vivos Therapeutics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Vivos Therapeutics is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivos Therapeutics	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

26.4% of Vivos Therapeutics shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 2.1% of Vivos Therapeutics shares are owned by insiders. Comparatively, 0.7% of Aethlon Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Aethlon Medical has a net margin of 0.00% compared to Vivos Therapeutics' net margin of -127.70%. Aethlon Medical's return on equity of -137.73% beat Vivos Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivos Therapeutics	-127.70%	-2,325.64%	-98.12%
Aethlon Medical	N/A	-137.73%	-105.87%

In the previous week, Aethlon Medical had 1 more articles in the media than Vivos Therapeutics. MarketBeat recorded 3 mentions for Aethlon Medical and 2 mentions for Vivos Therapeutics. Vivos Therapeutics' average media sentiment score of 0.94 beat Aethlon Medical's score of 0.53 indicating that Vivos Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vivos Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aethlon Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Vivos Therapeutics has a beta of 6.16, meaning that its share price is 516% more volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.41, meaning that its share price is 41% more volatile than the broader market.

Aethlon Medical has lower revenue, but higher earnings than Vivos Therapeutics. Vivos Therapeutics is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivos Therapeutics	$19.57M	0.29	-$21.17M	-$2.14	N/A
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A

Summary

Vivos Therapeutics beats Aethlon Medical on 10 of the 15 factors compared between the two stocks.

How does Aethlon Medical compare to Beyond Air?

Beyond Air (NASDAQ:XAIR) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends, media sentiment and valuation.

In the previous week, Beyond Air had 1 more articles in the media than Aethlon Medical. MarketBeat recorded 4 mentions for Beyond Air and 3 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 0.53 beat Beyond Air's score of -0.05 indicating that Aethlon Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beyond Air	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aethlon Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Beyond Air presently has a consensus price target of $200.00, indicating a potential upside of 3,510.11%. Given Beyond Air's stronger consensus rating and higher possible upside, research analysts plainly believe Beyond Air is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Aethlon Medical has lower revenue, but higher earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.68M	0.52	-$33.25M	-$88.00	N/A
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A

Beyond Air has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.41, meaning that its share price is 41% more volatile than the broader market.

31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 10.0% of Beyond Air shares are owned by company insiders. Comparatively, 0.7% of Aethlon Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Aethlon Medical has a net margin of 0.00% compared to Beyond Air's net margin of -432.99%. Aethlon Medical's return on equity of -137.73% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-432.99%	-350.00%	-101.34%
Aethlon Medical	N/A	-137.73%	-105.87%

Summary

Beyond Air beats Aethlon Medical on 8 of the 15 factors compared between the two stocks.

How does Aethlon Medical compare to CollPlant Biotechnologies?

Aethlon Medical (NASDAQ:AEMD) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment and analyst recommendations.

Aethlon Medical has a beta of 1.41, suggesting that its share price is 41% more volatile than the broader market. Comparatively, CollPlant Biotechnologies has a beta of 1.6, suggesting that its share price is 60% more volatile than the broader market.

In the previous week, Aethlon Medical had 2 more articles in the media than CollPlant Biotechnologies. MarketBeat recorded 3 mentions for Aethlon Medical and 1 mentions for CollPlant Biotechnologies. CollPlant Biotechnologies' average media sentiment score of 1.89 beat Aethlon Medical's score of 0.53 indicating that CollPlant Biotechnologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Aethlon Medical	Positive
CollPlant Biotechnologies	Very Positive

Aethlon Medical has a net margin of 0.00% compared to CollPlant Biotechnologies' net margin of -683.68%. Aethlon Medical's return on equity of -137.73% beat CollPlant Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-137.73%	-105.87%
CollPlant Biotechnologies	-683.68%	-218.81%	-139.28%

Aethlon Medical has higher earnings, but lower revenue than CollPlant Biotechnologies. CollPlant Biotechnologies is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A
CollPlant Biotechnologies	$2.37M	2.05	-$11.49M	-$1.45	N/A

CollPlant Biotechnologies has a consensus price target of $11.50, indicating a potential upside of 3,312.46%. Given CollPlant Biotechnologies' stronger consensus rating and higher possible upside, analysts plainly believe CollPlant Biotechnologies is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
CollPlant Biotechnologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

2.0% of Aethlon Medical shares are owned by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are owned by institutional investors. 0.7% of Aethlon Medical shares are owned by insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

CollPlant Biotechnologies beats Aethlon Medical on 9 of the 15 factors compared between the two stocks.

Get Aethlon Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AEMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AEMD vs. The Competition

Export

Metric	Aethlon Medical	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.70M	$56.12B	$6.87B	$12.54B
Dividend Yield	N/A	1.66%	2.68%	9.44%
P/E Ratio	-0.05	26.29	27.19	24.24
Price / Sales	N/A	0.67	510.44	87.79
Price / Cash	N/A	24.98	48.63	60.03
Price / Book	0.23	2.91	10.79	6.22
Net Income	-$7.15M	$1.46B	$3.59B	$331.84M
7 Day Performance	3.02%	-0.45%	-2.48%	-1.90%
1 Month Performance	-62.90%	-3.58%	2.85%	-0.95%
1 Year Performance	-94.18%	15.26%	25.29%	18.07%

Aethlon Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AEMD Aethlon Medical	0.45 of 5 stars	$0.72 +4.1%	N/A	-94.3%	$1.70M	N/A	N/A	10	Gap Down
NVNO enVVeno Medical	2.0449 of 5 stars	$11.02 -0.7%	N/A	-92.6%	$7.41M	N/A	N/A	30	News Coverage High Trading Volume
NXL Nexalin Technology	0.4338 of 5 stars	$0.36 +3.7%	N/A	-54.0%	$7.20M	$300K	N/A	3	News Coverage
VVOS Vivos Therapeutics	2.3564 of 5 stars	$0.48 -0.7%	$2.80 +484.6%	-93.9%	$6.70M	$17.44M	N/A	160	Gap Up
XAIR Beyond Air	2.2697 of 5 stars	$0.44 flat	$10.00 +2,177.9%	-91.1%	$6.33M	$7.68M	N/A	70	Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AEMD) was last updated on 7/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aethlon Medical (AEMD) Competitors

AEMD vs. NVNO, NXL, VVOS, XAIR, and CLGN

How does Aethlon Medical compare to enVVeno Medical?

Summary

How does Aethlon Medical compare to Nexalin Technology?

Summary

How does Aethlon Medical compare to Vivos Therapeutics?

Summary

How does Aethlon Medical compare to Beyond Air?

Summary

How does Aethlon Medical compare to CollPlant Biotechnologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aethlon Medical (AEMD) Competitors

AEMD vs. NVNO, NXL, VVOS, XAIR, and CLGN

How does Aethlon Medical compare to enVVeno Medical?

Is NVNO or AEMD more profitable?

Does the media prefer NVNO or AEMD?

Do analysts rate NVNO or AEMD?

Which has better valuation and earnings, NVNO or AEMD?

Do institutionals & insiders have more ownership in NVNO or AEMD?

Which has more volatility and risk, NVNO or AEMD?

Summary

How does Aethlon Medical compare to Nexalin Technology?

Do analysts rate AEMD or NXL?

Do institutionals & insiders hold more shares of AEMD or NXL?

Is AEMD or NXL more profitable?

Which has more risk and volatility, AEMD or NXL?

Does the media prefer AEMD or NXL?

Which has preferable valuation & earnings, AEMD or NXL?

Summary

How does Aethlon Medical compare to Vivos Therapeutics?

Do analysts recommend VVOS or AEMD?

Do insiders & institutionals have more ownership in VVOS or AEMD?

Is VVOS or AEMD more profitable?

Does the media refer more to VVOS or AEMD?

Which has more risk & volatility, VVOS or AEMD?

Which has preferable valuation & earnings, VVOS or AEMD?

Summary

How does Aethlon Medical compare to Beyond Air?

Does the media refer more to XAIR or AEMD?

Do analysts recommend XAIR or AEMD?

Which has stronger valuation and earnings, XAIR or AEMD?

Which has more volatility & risk, XAIR or AEMD?

Do insiders and institutionals have more ownership in XAIR or AEMD?

Is XAIR or AEMD more profitable?

Summary

How does Aethlon Medical compare to CollPlant Biotechnologies?

Which has more risk & volatility, AEMD or CLGN?

Does the media prefer AEMD or CLGN?

Is AEMD or CLGN more profitable?

Which has better earnings & valuation, AEMD or CLGN?

Do analysts prefer AEMD or CLGN?

Do institutionals & insiders believe in AEMD or CLGN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools